PMID- 19066084 OWN - NLM STAT- MEDLINE DCOM- 20090414 LR - 20190917 IS - 0065-1419 (Print) IS - 0065-1419 (Linking) VI - 105 DP - 2008 TI - Microglial activation and brain injury after intracerebral hemorrhage. PG - 59-65 AB - Microglial activation and thrombin formation contribute to brain injury after intracerebral hemorrhage (ICH). Tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1beta) are 2 major proinflammatory cytokines. In this study, we investigated whether thrombin stimulates TNF-alpha and IL-1beta secretion in vitro, and whether microglial inhibition reduces ICH-induced brain injury in vivo. There were 2 parts to this study. In the first part, cultured rat microglial cells were treated with vehicle, thrombin (5 and 10U/mL), or thrombin plus tuftsin (0.05 microg/mL), an inhibitor of microglia activation. Levels of TNF-alpha and IL-1beta in culture medium were measured by ELISA at 4, 8, and 24 h after thrombin treatment. In the second part of the study, rats received an intracerebral infusion of 100 microL autologous whole blood with or without 25 microg of tuftsin 1-3 fragment. Rats were killed at day 1 or day 3 for immunohistochemistry and brain water content measurement. We found that thrombin receptors were expressed in cultured microglia cells, and TNF-alpha and IL-1beta levels in the culture medium were increased after thrombin treatment. Tuftsin reduced thrombin-induced upregulation of TNF-alpha and IL-1beta. In vivo, microglia were activated after ICH, and intracerebral injection of tuftsin reduced brain edema in the ipsilateral basal ganglia (81.1 +/- 0.7% vs. 82.7 +/- 1.3% in vehicle-treated group; p < 0.05) after ICH. These results suggest a critical role of microglia activation in ICH-related brain injury. FAU - Wu, J AU - Wu J AD - Medical School, Zhejiang University, Hangzhou, China. FAU - Yang, S AU - Yang S FAU - Xi, G AU - Xi G FAU - Song, S AU - Song S FAU - Fu, G AU - Fu G FAU - Keep, R F AU - Keep RF FAU - Hua, Y AU - Hua Y LA - eng GR - NS-017760/NS/NINDS NIH HHS/United States GR - NS-039866/NS/NINDS NIH HHS/United States GR - NS-047245/NS/NINDS NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't PL - Austria TA - Acta Neurochir Suppl JT - Acta neurochirurgica. Supplement JID - 100962752 RN - 0 (CD11b Antigen) RN - 0 (Immunologic Factors) RN - 0 (Interleukin-1beta) RN - 0 (Ions) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 3.4.21.5 (Thrombin) RN - QF5336J16C (Tuftsin) SB - IM MH - Animals MH - Animals, Newborn MH - Brain Edema/metabolism/pathology MH - Brain Injuries/*etiology/*pathology MH - CD11b Antigen/metabolism MH - Cells, Cultured MH - Cerebral Cortex/cytology MH - Cerebral Hemorrhage/*complications MH - Disease Models, Animal MH - Immunologic Factors/pharmacology MH - Interleukin-1beta/metabolism MH - Ions/metabolism MH - Male MH - Microglia/drug effects/*physiology MH - Rats MH - Rats, Sprague-Dawley MH - Thrombin/pharmacology MH - Time Factors MH - Tuftsin/pharmacology MH - Tumor Necrosis Factor-alpha/metabolism MH - Up-Regulation/drug effects EDAT- 2008/12/11 09:00 MHDA- 2009/04/15 09:00 CRDT- 2008/12/11 09:00 PHST- 2008/12/11 09:00 [pubmed] PHST- 2009/04/15 09:00 [medline] PHST- 2008/12/11 09:00 [entrez] AID - 10.1007/978-3-211-09469-3_13 [doi] PST - ppublish SO - Acta Neurochir Suppl. 2008;105:59-65. doi: 10.1007/978-3-211-09469-3_13.